C12N 2760/18241
Use of virus, viral particle or viral elements as a vector
C12N2760/18241 (Use of virus, viral particle or viral elements as a vector) appears on 3 US grants and 9 published applications in this corpus.
Search patents in C12N- Granted patents
- 3
- Published applications
- 9
- Assignees
- 4
- Inventors
- 23
- Latest grant
- 14 Feb 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2015 | 0 | 1 |
| 2016 | 1 | 0 |
| 2017 | 0 | 1 |
| 2018 | 1 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 1 | 1 |
| 2024 | 0 | 1 |
| 2025 | 0 | 1 |
| 2026 | 0 | 3 |
By publication year. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12N 2760/18245Special targeting system for viral vectorsIndexing code3
- C12N 2760/18242Virus or viral particle as vehicleIndexing code0
- C12N 2760/18243Viral genome or elements thereof as genetic vectorIndexing code0
- C12N 2760/18244Chimeric viral vector comprising heterologous viral elements for production of another viralIndexing code0
Recent patents
- Nipah virus envelope pseudotyped lentiviruses and methods of their use14 Feb 2023US 11,576,982 B2The Regents of the University of California
- Nipah virus envelope pseudotyped lentiviruses and methods of their use4 Sep 2018US 10,064,958 B2The Regents of the University of California
- Nipah virus envelope pseudotyped lentiviruses and methods of their use8 Nov 2016US 9,486,539 B2The Regents of the University of California
- In vivo daric17 Sep 2026US 2026/0273058 A1Kelonia Therapeutics, Inc.
- Cd19-specific antibody constructs and compositions thereof30 Jul 2026US 2026/0217822 A1
- Lipid particles with cofusogens and methods of producing and using the same16 Jul 2026US 2026/0199238 A1Sana Biotechnology, Inc.
- Recombinant cedar virus chimeras21 Aug 2025US 2025/0263442 A1The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
- Modified paramyxoviridae attachment glycoproteins12 Dec 2024US 2024/0408192 A1Sana Biotechnology, Inc.
Most cited
By later US patents
- Nipah virus envelope pseudotyped lentiviruses and methods of their use7US 10,064,958 B2The Regents of the University of California · 2018
- Nipah virus envelope pseudotyped lentiviruses and methods of their use6US 11,576,982 B2The Regents of the University of California · 2023
- Nipah virus envelope pseudotyped lentiviruses and methods of their use6US 9,486,539 B2The Regents of the University of California · 2016